Skip to Content

Raia Drogasil SA RADL3

Morningstar Rating
BRL 27.60 −0.05 (0.18%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RADL3 is trading at a 795% premium.
Price
BRL 27.55
Fair Value
BRL 83.68
Uncertainty
Medium
1-Star Price
BRL 37.56
5-Star Price
BRL 56.52
Economic Moat
Gdqplr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RADL3 is a good fit for your portfolio.

Trading Information

Previous Close Price
BRL 27.65
Day Range
BRL 27.4627.72
52-Week Range
BRL 24.3030.15
Bid/Ask
BRL 0.00 / BRL 0.00
Market Cap
BRL 47.34 Bil
Volume/Avg
4.2 Mil / 7.6 Mil

Key Statistics

Price/Earnings (Normalized)
41.04
Price/Sales
1.31
Dividend Yield (Trailing)
0.71%
Dividend Yield (Forward)
0.71%
Total Yield
0.72%

Company Profile

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Large Growth
Total Number of Employees
57,708

Comparables

Valuation

Metric
RADL3
PGMN3
HYPE3
Price/Earnings (Normalized)
41.0448.7710.90
Price/Book Value
7.650.571.64
Price/Sales
1.310.112.41
Price/Cash Flow
23.523.6410.82
Price/Earnings
RADL3
PGMN3
HYPE3

Financial Strength

Metric
RADL3
PGMN3
HYPE3
Quick Ratio
0.480.371.31
Current Ratio
1.431.391.81
Interest Coverage
2.760.482.42
Quick Ratio
RADL3
PGMN3
HYPE3

Profitability

Metric
RADL3
PGMN3
HYPE3
Return on Assets (Normalized)
5.42%0.34%7.37%
Return on Equity (Normalized)
18.13%1.17%15.71%
Return on Invested Capital (Normalized)
13.25%6.21%11.67%
Return on Assets
RADL3
PGMN3
HYPE3
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncZmlhrdfYlbn$15.4 Bil
RADLY
Raia Drogasil SA ADRVsshz$9.2 Bil
ALBHF
Alibaba Health Information Technology LtdPrxnm$6.7 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRNwklsq$6.6 Bil
CLCGY
Clicks Group Ltd ADRNvlrtpj$4.0 Bil
SDGCF
Sundrug Co LtdZkqgb$3.0 Bil
SGIPF
Sugi Holdings Co LtdFsrq$2.8 Bil
SAEYY
Redcare Pharmacy NV ADRNktmvbd$2.4 Bil
SHPPF
Redcare Pharmacy NVHwgqx$2.2 Bil
ZRSEF
DocMorris AGWlftkn$964.3 Mil

Sponsor Center